Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Aug;42(8):2194-2201.
doi: 10.1002/hed.26144. Epub 2020 Mar 27.

Oligometastatic head and neck cancer: Comprehensive review

Affiliations
Review

Oligometastatic head and neck cancer: Comprehensive review

Toms Vengaloor Thomas et al. Head Neck. 2020 Aug.

Abstract

There are limited data available regarding the management of oligometastatic squamous cell carcinoma of the head and neck (SCCHN) patients, and no consensus guidelines are available. The objective is to review the available literature for the management of oligometastatic SCCHN. Articles were selected from English Medline literature between 1995 and 2018, searched by using the keywords: oligometastatic SCCHN/metastasectomy/stereotactic body radiation treatment (SBRT). With the available data, oligometastatic SCCHN patients appear to behave differently and tend to have a better prognosis than those with widespread metastases. Retrospective evidence suggests that the aggressive treatment of the primary disease and local treatment of the metastatic sites improves survival in oligometastatic SCCHN at diagnosis. The definitive treatment of the distant metastatic sites using metastasectomy or SBRT correlates with better survival in oligorecurrent patients. Oligometastatic SCCHN patients may have a better prognosis if treated aggressively.

Keywords: isolated metastasis; metastasectomy; oligometastasis; single metastasis; stereotactic body radiation treatment (SBRT).

PubMed Disclaimer

References

REFERENCES

    1. Hellman S, Weichselbaum RR. Oligometastases. J Clin Oncol. 1995;13(1):8-10.
    1. Weichselbaum RR, Hellman S. Oligometastases revisited. Nat Rev Clin Oncol. 2011;8(6):378-382.
    1. NCCN. National Comprehensive Cancer Network Guidelines. NCCN guidelines. 2019. https://www.nccn.org. Accessed August 24, 2019.
    1. Sun XS, Michel C, Babin E, et al. Approach to oligometastatic disease in head and neck cancer, on behalf of the GORTEC. Future Oncol. 2018;14(9):877-889.
    1. Dingemans AC, Hendriks LEL, Berghmans T, et al. Definition of synchronous oligo-metastatic non-small cell lung cancer-a consensus report. J Thorac Oncol. 2019;14(12):2109-2119.

LinkOut - more resources